RCVS announces clinical career pathways event
"The results indicated that there was a need for a pathway for practitioners once they've achieved the status" - Dr Linda Prescott-Clements.
The Royal College of Veterinary Surgeons (RCVS) is set to hold an event on developing clear clinical career pathways for veterinary surgeons.
Taking place at The View at the RCVS, 'Exploring Clinical Career Pathways for the Future' will begin at 9.30am on Wednesday 7 December 2022.
Running until 5pm, the event aims to discuss enhancing clinical career pathways to improve accessibility and flexibility for those with Advanced Practitioner (AP) status.
RCVS director of education, Dr Linda Prescott-Clements, discussed the intention of the event, following a review of the College's AP status: “The results indicated that there was some confusion about AP status amongst the profession and the wider public, and that there was a need for a pathway for practitioners once they’ve achieved the status that would allow for a greater sense of progression and professional growth.
“With this event, we hope to get discussions going on how to solve some of the identified issues around the status, with a view to making some fundamental improvements in the future as well as a concerted effort to demonstrate the status’ value to both the professions and the public.”
Attendance for the event is by invite only, and the day will feature presentations to clarify the background behind AP status and the review.
Following this, discussions will take place in break-out groups, on topics such as identifying a career pathway for vets working in clinical practice, and clarifying the roles within the pathways to ensure understanding within and outside the profession.
In the event that there may be capacity for additional guests to attend, veterinary surgeons or representatives of an organisation wishing to attend can contact the RCVS Events Team on events@rcvs.org.uk to request an invite.
Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.
